Designing trials for new cystic fibrosis modulators

Lancet Respir Med. 2018 Jul;6(7):484-486. doi: 10.1016/S2213-2600(18)30195-4. Epub 2018 May 31.
No abstract available

Publication types

  • Review

MeSH terms

  • Chloride Channel Agonists / therapeutic use*
  • Clinical Trial Protocols as Topic*
  • Cystic Fibrosis / drug therapy*
  • Cystic Fibrosis Transmembrane Conductance Regulator / drug effects*
  • Humans

Substances

  • Chloride Channel Agonists
  • Cystic Fibrosis Transmembrane Conductance Regulator